These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30919595)

  • 1. Enhanced Programmed Death 1 and Diminished Programmed Death Ligand 1 Up-Regulation Capacity of Post-Activated Lupus B Cells.
    Stefanski AL; Wiedemann A; Reiter K; Hiepe F; Lino AC; Dörner T
    Arthritis Rheumatol; 2019 Sep; 71(9):1539-1544. PubMed ID: 30919595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
    Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
    Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.
    Liu MF; Weng CT; Weng MY
    J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of PD-1/PD-L1 signaling axis on the interaction between CD19
    Xie Z; Dai L; He H; Hong D; Tang H; Xu W; Chen Z; Wang H; Li B; Xie C; Wang Y
    Adv Rheumatol; 2023 Oct; 63(1):51. PubMed ID: 37848996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 governed cross-talk of exhausted CD8
    Wang K; Zhao J; Feng X; He S; Li J; Sun F; Xu Z; Yang H; Ye J; Cao L; Ye S
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38233074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The proportion of CD19
    Xie Z; Dai L; He H; Hong D; Wang Y; Xu W; Chen Z; Li B; Xie C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):148-157. PubMed ID: 38284256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with systemic lupus erythematosus show increased proportions of CD19
    Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
    Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity.
    Hirahara S; Katsumata Y; Kawasumi H; Kawaguchi Y; Harigai M
    Lupus; 2020 Jun; 29(7):686-696. PubMed ID: 32264742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Phenotyping of CD11c
    Rincon-Arevalo H; Wiedemann A; Stefanski AL; Lettau M; Szelinski F; Fuchs S; Frei AP; Steinberg M; Kam-Thong T; Hatje K; Keller B; Warnatz K; Radbruch A; Lino AC; Schrezenmeier E; Dörner T
    Front Immunol; 2021; 12():635615. PubMed ID: 33777025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis.
    Grywalska E; Smarz-Widelska I; Korona-Głowniak I; Mertowski S; Gosik K; Hymos A; Ludian J; Niedźwiedzka-Rystwej P; Roliński J; Załuska W
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33121190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of total glucosides of paeony on PD-1/PD-L1 expression in primary Sjögren's syndrome.
    Chen Y; Wang Y; Xu L; Zhu W; Xu C; Xu M; Guo L; Hu W; Xu D; Jing R; Zhu Y; He J; Xu B
    Int J Rheum Dis; 2019 Feb; 22(2):200-206. PubMed ID: 30338648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α and TGF-β counter-regulate PD-L1 expression on monocytes in systemic lupus erythematosus.
    Ou JN; Wiedeman AE; Stevens AM
    Sci Rep; 2012; 2():295. PubMed ID: 22389764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased expressions of programmed death 1 (PD-1) and its ligands in peripheral CD3(+) T cells and CD19(+) B cells in patients with hepatocellular carcinoma].
    Liu W; Chai L; Liang J; Lu Z; Yang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1243-7. PubMed ID: 27609582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-
    Moriyama R; Katsumata Y; Okamoto Y; Harigai M
    Lupus; 2024 Jul; 33(8):816-827. PubMed ID: 38622764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
    Deepak HB; Prince SE; Deshpande P
    Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
    Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
    J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of B-cell activation and antibody production by triggering inhibitory signals via the PD-1/PD-ligand pathway.
    Buermann A; Römermann D; Baars W; Hundrieser J; Klempnauer J; Schwinzer R
    Xenotransplantation; 2016 Sep; 23(5):347-56. PubMed ID: 27613101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.